ea0071026 | The importance of including post-operative thyroglobulin levels in the decision-making process towards adjuvant radioiodine treatment in patients with papillary thyroid cancer | BES2020
Sarah Billet
, Annick Van den Bruel
The treatment of papillary thyroid cancer consist of surgery and if indicated post-surgical administration of radioiodine with the initiation of thyroid hormone substitution. Whether or not a patient receives a post-operative radioiodine treatment largely depends on the pathological staging (TNM).Through observational data, the benefit of additional radioiodine treatment was only significant in patients with thyroid cancer classified as high risk accordi...